Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model

Published:2017-03-02 Issue:5 Volume:13 Page:2071-2078
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:en
Short-container-title:

Author:

Wiciński Michał,Malinowski Bartosz,Węclewicz Mateusz M.,Grześk Elżbieta,Grześk Grzegorz

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnological Breakthroughs in Resveratrol Synthesis and Health Advancements;Current Pharmaceutical Biotechnology;2024-06-27

2. Protective Effects of Curcumin and Resveratrol on Kidney Tissue on Cadmiuminduced Oxidative Stress in Rats;Gazi Medical Journal;2024-04-01

3. Phytochemical Supplementation Regulates Immune Function and Modulates Cell Survival Signaling, Enhancing Neuroprotection and Cognitive Functions in Aging;Neuroprotective Effects of Phytochemicals in Brain Ageing;2024

4. Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria;Psychiatry and Clinical Psychopharmacology;2023-06-20

5. Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial;Endocrine;2022-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP